title: Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA.
authors.affiliation: EORTC Data Center, Brussels, Belgium.
authors.forename: S
authors.initials: S
authors.lastname: Suciu
authors.forename: G
authors.initials: G
authors.lastname: Solbu
authors.forename: R
authors.initials: R
authors.lastname: Zittoun
authors.forename: M
authors.initials: M
authors.lastname: Hayat
authors.forename: R
authors.initials: R
authors.lastname: Willemze
authors.forename: T
authors.initials: T
authors.lastname: de Witte
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000401:mortality; D002986:Clinical Trials as Topic / Q000379:methods*; D003131:Combined Modality Therapy; D005060:Europe / Q000453:epidemiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000601:surgery* / Q000628:therapy; D015993:Life Tables; D012074:Remission Induction; D012306:Risk; D015996:Survival Rate